Th17 Cells, Glucocorticoid Resistance, and Depression

Overview

Journal Cells

Publisher MDPI

Specialties Biochemistry
Biophysics
Cell Biology
Molecular Biology

Date 2023 Dec 9

PMID 38067176

Authors

Julia N Khantakova

Anastasia Mutovina

Kseniya A Ayriyants

Natalia P Bondar

Affiliations

Soon will be listed here.

Abstract

Depression is a severe mental disorder that disrupts mood and social behavior and is one of the most common neuropsychological symptoms of other somatic diseases. During the study of the disease, a number of theories were put forward (monoamine, inflammatory, vascular theories, etc.), but none of those theories fully explain the pathogenesis of the disease. Steroid resistance is a characteristic feature of depression and can affect not only brain cells but also immune cells. T-helper cells 17 type (Th17) are known for their resistance to the inhibitory effects of glucocorticoids. Unlike the inhibitory effect on other subpopulations of T-helper cells, glucocorticoids can enhance the differentiation of Th17 lymphocytes, their migration to the inflammation, and the production of IL-17A, IL-21, and IL-23 in GC-resistant disease. According to the latest data, in depression, especially the treatment-resistant type, the number of Th17 cells in the blood and the production of IL-17A is increased, which correlates with the severity of the disease. However, there is still a significant gap in knowledge regarding the exact mechanisms by which Th17 cells can influence neuroinflammation in depression. In this review, we discuss the mutual effect of glucocorticoid resistance and Th17 lymphocytes on the pathogenesis of depression.

Citing Articles

Immunophenotypic Implications of Reverse-Circadian Glucocorticoid Treatment in Congenital Adrenal Hyperplasia.

Nowotny H, Choi H, Ziegler S, Doll N, Bauerle A, Welp A Int J Mol Sci. 2025; 26(4).

PMID: 40003944 PMC: 11855454. DOI: 10.3390/ijms26041479.

A Review on Asthma and Allergy: Current Understanding on Molecular Perspectives.

Gohal G, Moni S, Bakkari M, Elmobark M J Clin Med. 2024; 13(19).

PMID: 39407835 PMC: 11476424. DOI: 10.3390/jcm13195775.

Combining Metagenomics, Network Pharmacology and RNA-Seq Strategies to Reveal the Therapeutic Effects and Mechanisms of Qingchang Wenzhong Decoction on Inflammatory Bowel Disease in Mice.

Yuan Y, Hu H, Sun Z, Wang W, Wang Z, Zheng M Drug Des Devel Ther. 2024; 18:4273-4289.

PMID: 39347539 PMC: 11438451. DOI: 10.2147/DDDT.S473688.

"Air That Once Was Breath" Part 2: Wildfire Smoke and Airway Disease - "Climate Change, Allergy and Immunology" Special IAAI Article Collection: Collegium Internationale Allergologicum Update 2023.

Bowman W, Schmidt R, Sanghar G, Thompson Iii G, Ji H, Zeki A Int Arch Allergy Immunol. 2024; 185(6):617-630.

PMID: 38527432 PMC: 11548886. DOI: 10.1159/000536576.

"Air That Once Was Breath" Part 1: Wildfire-Smoke-Induced Mechanisms of Airway Inflammation - "Climate Change, Allergy and Immunology" Special IAAI Article Collection: Collegium Internationale Allergologicum Update 2023.

Bowman W, Schmidt R, Sanghar G, Thompson Iii G, Ji H, Zeki A Int Arch Allergy Immunol. 2024; 185(6):600-616.

PMID: 38452750 PMC: 11487202. DOI: 10.1159/000536578.

References

Tsujimura S, Saito K, Nawata M, Nakayamada S, Tanaka Y . Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis. Ann Rheum Dis. 2007; 67(3):380-8. DOI: 10.1136/ard.2007.070821. View

Liu Q, Xin W, He P, Turner D, Yin J, Gan Y . Interleukin-17 inhibits adult hippocampal neurogenesis. Sci Rep. 2014; 4:7554. PMC: 4271266. DOI: 10.1038/srep07554. View

Sun Y, Drevets W, Turecki G, Li Q . The relationship between plasma serotonin and kynurenine pathway metabolite levels and the treatment response to escitalopram and desvenlafaxine. Brain Behav Immun. 2020; 87:404-412. DOI: 10.1016/j.bbi.2020.01.011. View

Elizei S, Poormasjedi-Meibod M, Wang X, Kheirandish M, Ghahary A . Kynurenic acid downregulates IL-17/1L-23 axis in vitro. Mol Cell Biochem. 2017; 431(1-2):55-65. DOI: 10.1007/s11010-017-2975-3. View

Carvalho L, Bergink V, Sumaski L, Wijkhuijs J, Hoogendijk W, Birkenhager T . Inflammatory activation is associated with a reduced glucocorticoid receptor alpha/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder. Transl Psychiatry. 2014; 4:e344. PMC: 3905228. DOI: 10.1038/tp.2013.118. View

Iqbal M, Baello S, Javam M, Audette M, Gibb W, Matthews S . Regulation of Multidrug Resistance P-Glycoprotein in the Developing Blood-Brain Barrier: Interplay between Glucocorticoids and Cytokines. J Neuroendocrinol. 2016; 28(3):12360. DOI: 10.1111/jne.12360. View

Schiweck C, Valles-Colomer M, Arolt V, Muller N, Raes J, Wijkhuijs A . Depression and suicidality: A link to premature T helper cell aging and increased Th17 cells. Brain Behav Immun. 2020; 87:603-609. DOI: 10.1016/j.bbi.2020.02.005. View

Lee Y, Awasthi A, Yosef N, Quintana F, Xiao S, Peters A . Induction and molecular signature of pathogenic TH17 cells. Nat Immunol. 2012; 13(10):991-9. PMC: 3459594. DOI: 10.1038/ni.2416. View

Banuelos J, Cao Y, Shin S, Lu N . Immunopathology alters Th17 cell glucocorticoid sensitivity. Allergy. 2016; 72(3):331-341. PMC: 5315659. DOI: 10.1111/all.13051. View

10.

Vazquez-Tello A, Halwani R, Hamid Q, Al-Muhsen S . Glucocorticoid receptor-beta up-regulation and steroid resistance induction by IL-17 and IL-23 cytokine stimulation in peripheral mononuclear cells. J Clin Immunol. 2012; 33(2):466-78. DOI: 10.1007/s10875-012-9828-3. View

11.

Westfall S, Caracci F, Estill M, Frolinger T, Shen L, Pasinetti G . Chronic Stress-Induced Depression and Anxiety Priming Modulated by Gut-Brain-Axis Immunity. Front Immunol. 2021; 12:670500. PMC: 8264434. DOI: 10.3389/fimmu.2021.670500. View

12.

Hiles S, Baker A, de Malmanche T, Attia J . A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: exploring the causes of heterogeneity. Brain Behav Immun. 2012; 26(7):1180-8. DOI: 10.1016/j.bbi.2012.06.001. View

13.

Cerboni S, Gehrmann U, Preite S, Mitra S . Cytokine-regulated Th17 plasticity in human health and diseases. Immunology. 2020; 163(1):3-18. PMC: 8044333. DOI: 10.1111/imm.13280. View

14.

Sviridova A, Rogovskii V, Kudrin V, Pashenkov M, Boyko A, Melnikov M . The role of 5-HT-receptors in fluoxetine-mediated modulation of Th17- and Th1-cells in multiple sclerosis. J Neuroimmunol. 2021; 356:577608. DOI: 10.1016/j.jneuroim.2021.577608. View

15.

Moncrieff J, Cooper R, Stockmann T, Amendola S, Hengartner M, Horowitz M . The serotonin theory of depression: a systematic umbrella review of the evidence. Mol Psychiatry. 2022; 28(8):3243-3256. PMC: 10618090. DOI: 10.1038/s41380-022-01661-0. View

16.

Dvojkovic A, Nikolac Perkovic M, Sagud M, Nedic Erjavec G, Mihaljevic Peles A, Strac D . Effect of vortioxetine vs. escitalopram on plasma BDNF and platelet serotonin in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry. 2020; 105:110016. DOI: 10.1016/j.pnpbp.2020.110016. View

17.

Kawanokuchi J, Shimizu K, Nitta A, Yamada K, Mizuno T, Takeuchi H . Production and functions of IL-17 in microglia. J Neuroimmunol. 2008; 194(1-2):54-61. DOI: 10.1016/j.jneuroim.2007.11.006. View

18.

Dong C . TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol. 2008; 8(5):337-48. DOI: 10.1038/nri2295. View

19.

Hennings J, Uhr M, Klengel T, Weber P, Putz B, Touma C . RNA expression profiling in depressed patients suggests retinoid-related orphan receptor alpha as a biomarker for antidepressant response. Transl Psychiatry. 2015; 5:e538. PMC: 4429173. DOI: 10.1038/tp.2015.9. View

20.

Nadeem A, Ahmad S, Al-Harbi N, Fardan A, El-Sherbeeny A, Ibrahim K . IL-17A causes depression-like symptoms via NFκB and p38MAPK signaling pathways in mice: Implications for psoriasis associated depression. Cytokine. 2017; 97:14-24. DOI: 10.1016/j.cyto.2017.05.018. View